HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $10 Price Target

Benzinga · 03/20 10:47
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.